 |
|
1-888-632-5353
M-F 8 AM - 9 PM EST
|
|
is Searching for
Plans in ZIP Code
|
Sorry, that ZIP code
was not found.
Try Again
|
|
|
is Searching for
Dentist in ZIP Code
|
|
|
you are here: DentalPlans.com > Dental Health Articles > Research > Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones
| |
|
|
|
Updated: 11/7/2006 12:51:46 PM |
|
|
Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.
A study - the largest cross-sectional examination of how the long-term use of topiramate affects kidney-stone formation - appears in the October issue of the American Journal of Kidney Diseases.
Several case reports have described an association between topiramate and the development of kidney stones, but this complication had not been well recognized and physicians have not informed patients about the risk, the UT Southwestern researchers said. More important, the mechanism of stone formation was largely unknown previously.
“The wide-spread and escalating use of topiramate emphasizes the importance of considering the long-term impact of this drug on kidney-stone formation,” said Dr. Khashayar Sakhaee, senior author of the study and chief of mineral metabolism at UT Southwestern.
More than 29 million Americans suffer from migraines, with women being affected three times more often than men, according to the National Headache Foundation.
“Topiramate is probably one of the most commonly prescribed and most effective neurological medications right now,” said Dr. Dion Graybeal, assistant professor of neurology and an author of the study.
Dr. Graybeal and other researchers at UT Southwestern say the next step is to develop a way to block the development of kidney stones for users.
The study comprised two phases. Thirty-two individuals already being treated with topiramate and 50 normal volunteers were enrolled in a cross-sectional study in which their blood and urine were tested for kidney-stone risk. A short-term study also was conducted in seven individuals to assess stone risk before and three months after taking topiramate. All patients were evaluated at UT Southwestern’s General Clinical Research Center.
Researchers found that taking topiramate on a long-term basis, or for about one year, caused systemic metabolic acidosis - a buildup of excessive acid in the blood - as a result of the inability of the kidney to excrete acid. Topiramate use also increased the urine pH and lowered urine citrate, an important inhibitor of kidney-stone formation.
“These changes increase the propensity to form calcium phosphate stones,” Dr. Sakhaee said.
In the short-term study, urinary calcium and oxalate - a chemical compound that binds strongly with calcium and is found in most calcium stones - did not significantly change in people taking topiramate.
Kidney stones are solid deposits that form in the kidneys from substances excreted in the urine. When waste materials in urine do not dissolve completely, microscopic particles begin to form and, over time, grow into kidney stones.
Before this study, the rate of kidney-stone formation with topiramate was reported as 1.5 percent. The low incidence rate may be an underestimation due to the short length of observation and the lack of ongoing kidney-stone surveillance and data collection for this drug, said Dr. Sakhaee, holder of the BeautiControl Cosmetics Inc. Professorship in Mineral Metabolism and Osteoporosis.
“There is a legitimate concern for the occurrence of kidney stones with long-term topiramate treatment,” said Dr. Sakhaee said. “Studies are needed to explore optimal measures to prevent kidney-stone formation with topiramate use.”
Other UT Southwestern researchers contributing to the study were Dr. Orson Moe, director of the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, Dr. Naim Maalouf, assistant professor of internal medicine and Dr. Brian J. Welch, a postdoctoral fellow in internal medicine.
The research was supported by the National Institutes of Health.
© 2006 HealthNewsDigest.com
|
|
|
|
|
|
|
|
The materials and articles published on DentalPlans.com are for informational purposes only. Although DentalPlans.com strives to be accurate and complete, the information is provided without liability for errors. DentalPlans.com does not warrant the accuracy or completeness of the information, text graphics, links, or other items contained on DentalPlans.com.
DentalPlans.com expressly disclaims liability for errors or omissions in these materials and DentalPlans.com makes no commitment to update the information on DentalPlans.com.
DentalPlans.com expressly disclaims all liability for the use or interpretation by others of information on DentalPlans.com. Decisions based on information contained on DentalPlans.com are the sole responsibility of the visitors, and visitors agree to hold DentalPlans.com and its Affiliates harmless against any claims for damages arising from decisions visitors make on such information.
Nothing on DentalPlans.com constitutes medical advice or other forms of advice. DentalPlans.com assumes no responsibility for material created or published by third parties linked to DentalPlans.com with or without DentalPlans.coms knowledge.
|
|
| |
|
|
The DENTALPLANS.COM website is administered by DENTALPLANS.COM, INC., a licensed Florida Discount Medical Plan Organization, 8100 S.W. 10th Street Suite #2000, Plantation, FL 33324. Plans and Programs offered by DentalPlans.com are not health insurance policies. Plans and Programs offered by DentalPlans.com provide discounts at certain health care providers for medical services. Plans and Programs offered by DentalPlans.com do not make payments directly to the providers of medical services. The Plan or Program member is obligated to pay for all health care services but will receive a discount from those health care providers who have contracted with the Plan, Program or discount plan organization.
|
Special promotions including but not limited to additional months free and Membership Rewards® points from American Express are not available to California residents.
© 1999-2011 DentalPlans.com, Inc. All Rights Reserved. Patents Pending. Blue Cross and Blue Shield of Florida is an Independent Licensee of the Blue Cross and Blue Shield Association. |
 
|
|
| |
|  |